Clinical and sonographic discrimination between fibromyalgia and spondyloarthopathy in inflammatory bowel disease with musculoskeletal pain.
Adult
Colitis, Ulcerative
/ complications
Crohn Disease
/ complications
Diagnosis, Differential
Female
Fibromyalgia
/ diagnosis
Humans
Inflammatory Bowel Diseases
/ complications
Male
Middle Aged
Musculoskeletal Pain
/ epidemiology
Prevalence
Psoriasis
/ epidemiology
Smoking
/ epidemiology
Spondylarthritis
/ diagnosis
Ultrasonography
disease activity indices
fibromyalgia
inflammatory bowel disease
spondyloarthopathy
ultrasonography
Journal
Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501
Informations de publication
Date de publication:
01 Oct 2020
01 Oct 2020
Historique:
received:
08
11
2019
revised:
13
01
2020
pubmed:
19
2
2020
medline:
23
1
2021
entrez:
19
2
2020
Statut:
ppublish
Résumé
Joint pain is common in subjects with IBD and is linked to several factors including SpA, drug therapy, concomitant OA or FM. The primary aim of this study was to estimate the prevalence of primary FM and concomitant FM and SpA in a cohort of patients with IBD utilizing clinical and US assessment. A total of 301 consecutive cases with IBD attending two IBD Units were assessed by a rheumatologist for Assessment of SpondyloArthritis International Society criteria fulfilment for SpA or the 2010 ACR criteria for FM. Some 158 cases also had US entheseal examination on large insertions in the upper and lower limbs. Thirty-seven IBD patients (12%) met the ACR criteria for primary FM with 9% presenting with primary FM and 3.3% presenting with concomitant FM and SpA. Meeting FM criteria was not related to smoking, sedentary job, BMI or the presence of psoriasis. FM patients presented higher Leeds Enthesitis Index, BASDAI and BASFI scores than SpA patients. At US examination, patients who satisfied the Assessment of SpondyloArthritis International Society criteria for SpA had significantly higher mean enthesis or patient power Doppler positive as compared with the IBD and FM group (P < 0.001). We found that FM occurred in 12% of SpA patients and in this setting SpA disease activity indices performed poorly. US examination in a large patient subgroup showed a promising discriminating capacity between FM and SpA in IBD patients.
Identifiants
pubmed: 32068873
pii: 5739991
doi: 10.1093/rheumatology/keaa036
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2857-2863Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.